Amundi
ARNA

Amundi’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Amundi’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,869
Closed -$265K – 1750
2021
Q4 		$265K Hold
2,869
– – ﹤0.01% 1461
2021
Q3 		$171K Hold
2,869
– – ﹤0.01% 1456
2021
Q2 		$196K Buy
+2,869
New +$187K ﹤0.01% 1382

Amundi's ARNA Position: Q1 2022 in Review

Amundi sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 2,869 shares — an estimated $265K sold.

Amundi first reported a position in ARNA in Q2 2021 and held it in 3 quarters. The position peaked at $265K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Amundi reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Amundi sold 2,869 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $265K.
  • Amundi first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 3 quarters.
  • Amundi's Arena Pharmaceuticals Inc position peaked at $265K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Amundi's 13F filing for Q1 2022, filed 16 May 2022.